219.50p+3.00 (+1.39%)22 Nov 2024, 16:35
Jump to:
Spire Healthcare Group PLC Fundamentals
Company Name | Spire Healthcare Group PLC | Last Updated | 2024-11-22 |
---|---|---|---|
Industry | Medical Care Facilities | Sector | Healthcare |
Shares in Issue | 403.085 m | Market Cap | £884.88 m |
PE Ratio | 32.28 | Dividend per Share | £0.01 |
Dividend Yield | 0.96 | Dividend Cover | 13.20 |
EPS | £0.07 | EPS Growth (%) | 2.73 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.5437 | Debt Equity Ratio | 1.5595 |
Asset Equity Ratio | 3.1178 | Cash Equity Ratio | 0.0582 |
Quick Ratio | 0.4616 | Current Ratio | 0.70 |
Price To Book Value | 1.1955 | ROCE | 0 |
Spire Healthcare Group PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Interim | 2024-05-23 | 2024-06-21 | GBP | 0.0210 | |
Prelim | 2023-05-25 | 2023-06-23 | GBP | 0.0050 |
Spire Healthcare Group PLC Company Financials
Assets | 2023 | 2022 | 2021 |
---|---|---|---|
Tangible Assets | £1.62 bn | £1.58 bn | £1.55 bn |
Intangible Assets | £438.30 m | £345.80 m | £334.80 m |
Investments | £10.00 m | £4.60 m | £2.30 m |
Total Fixed Assets | £2.07 bn | £1.94 bn | £1.89 bn |
Stocks | £44.30 m | £40.60 m | £40.20 m |
Debtors | £99.70 m | £84.80 m | £80.80 m |
Cash & Equivalents | £49.60 m | £74.20 m | £202.60 m |
Other Assets | £400,000.00 | £5.00 m | 0 |
Total Assets | £2.29 bn | £2.16 bn | £2.24 bn |
Liabilities | 2023 | 2022 | 2021 |
---|---|---|---|
Creditors within 1 year | £317.60 m | £283.40 m | £302.10 m |
Creditors after 1 year | £1.23 bn | £1.15 bn | £1.23 bn |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £1.55 bn | £1.43 bn | £1.53 bn |
Net assets | £737.80 m | £725.10 m | £704.80 m |
Equity | 2023 | 2022 | 2021 |
---|---|---|---|
Called up share capital | £4.00 m | £4.00 m | £4.00 m |
Share Premium | £830.00 m | £830.00 m | £826.90 m |
Profit / Loss | £34.60 m | £3.90 m | -£1.90 m |
Other Equity | £739.90 m | £731.00 m | £709.60 m |
Preference & Minorities | -£2.10 m | -£5.90 m | -£4.80 m |
Total Capital Employed | £737.80 m | £725.10 m | £704.80 m |
Ratios | 2023 | 2022 | 2021 |
---|---|---|---|
Debt Ratio | £0.61 | £0.60 | £0.62 |
Debt-to-Equity | £1.56 | £1.50 | £1.65 |
Assets / Equity | 3.1178 | 3.1178 | 3.1178 |
Cash / Equity | 0.0582 | 0.0582 | 0.0582 |
EPS | £0.06 | £0.01 | -£0.07 |
Cash Flow | 2023 | 2022 | 2021 |
---|---|---|---|
Cash from operating activities | £215.50 m | £181.60 m | £183.80 m |
Cashflow before financing | £132.60 m | -£33.10 m | £144.60 m |
Increase in Cash | -£24.60 m | -£128.40 m | £96.30 m |
Income | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | £1.36 bn | £1.20 bn | £1.11 bn |
Cost of sales | £734.80 m | £660.10 m | £615.00 m |
Gross Profit | £624.20 m | £538.40 m | £491.20 m |
Operating Profit | £126.20 m | £95.40 m | £87.00 m |
Pre-Tax profit | £34.60 m | £3.90 m | -£1.90 m |
Spire Healthcare Group PLC Company Background
Sector | Healthcare |
---|---|
Activities | Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital that has delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs, and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints andincreasing demand from a growing population with longer life expectancy. |
Latest Interim Date | 12 Sep 2024 |
Latest Fiscal Year End Date | 29 Feb 2024 |
Spire Healthcare Group PLC Directors
Appointed | Name | Position |
---|---|---|
2019-05-16 | Mr. Peter Richard Bamford | Non-Executive Director,Deputy Chairman |
2016-06-27 | Mr. Robert Earl Lerwill | Non-Executive Director |
2018-04-19 | Mr. Andrew White | Executive Director |
2017-05-26 | Mr. John Gildersleeve | Non-Executive Director,Deputy Chairman |
2022-04-01 | Mr. Garry Watts MBE | Non-Executive Director,Chairman |
2018-04-19 | Mr. Simon Gordon | Executive Director,Chief Financial Officer |
2024-04-04 | Sir Ian Michael Cheshire | Non-Executive Director,Chairman |
2017-04-25 | Mr. Robert Roger | Executive Director,Chief Executive Officer |
2023-04-03 | Mr. Anthony Rhys Bourne | Non-Executive Director |
2024-04-04 | Mr. Jitesh Himatlal Sodha | Executive Director,Chief Financial Officer |
2024-04-04 | Ms. Adele Helen Anderson | Non-Executive Director |
2024-04-04 | Mr. Simon Nicholas Rowlands | Non-Executive Director |
2015-07-01 | Dr. Supraj Rajagopalan | Non-Executive Director |
2024-04-04 | Professor Dame Janet Elizabeth Husband | Non-Executive Director,Vice Chairman |
2024-09-17 | Mr. Justinian Joseph Ash | Executive Director,Chief Executive Officer |
2024-04-04 | Ms. Jenny Kay | Non-Executive Director |
2024-05-15 | Mr. Harbant Samra | Executive Director,Chief Financial Officer |
Spire Healthcare Group PLC Contact Details
Company Name | Spire Healthcare Group PLC |
---|---|
Address | 3 Dorset Rise, London, EC4Y 8EN |
Telephone | |
Website | https://www.spirehealthcare.com |
Spire Healthcare Group PLC Advisors
Stockbroker | J.P. Morgan Cazenove Ltd |
---|---|
Phone | +44 2077424000 |
Remuneration Consultant | Deloitte LLP |
---|---|
Phone | +44 2079363000 |
Fax | +44 2075831198 |
Stockbroker | Bank of America Merrill Lynch |
---|---|
Phone | +44 2076281000 |
Fax | +44 2078672867 |
Financial PR Adviser | Maitland |
---|---|
Phone | +44 2073795151 |
Fax | +44 2073796161 |
Solicitor | Freshfields Bruckhaus Deringer |
---|---|
Phone | +44 2079364000 |
Fax | +44 2078327001 |
Registrar | Equiniti Limited |
---|
Solicitor | Allen & Overy LLP |
---|---|
Phone | +44 2030880000 |
Fax | +44 207339999 |
Auditor | EY |
---|---|
Phone | +44 2079512000 |
Fax | +44 2079511345 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine